2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

…, RM Silver, RW Simms, J Varga, JE Pope - Arthritis & …, 2013 - Wiley Online Library
Objective The 1980 American College of Rheumatology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

…, EF Mysler, JAP Da Silva, G Poór, JE Pope… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …

[HTML][HTML] A randomized trial of arthroscopic surgery for osteoarthritis of the knee

…, SH Griffin, LM D'Ascanio, JE Pope… - … England Journal of …, 2008 - Mass Medical Soc
Background The efficacy of arthroscopic surgery for the treatment of osteoarthritis of the
knee is unknown. Methods We conducted a single-center, randomized, controlled trial of …

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

…, D Khanna, U Müller-Ladner, JE Pope… - Annals of the …, 2014 - ard.bmj.com
Objective Earlier detection of pulmonary arterial hypertension (PAH), a leading cause of death
in systemic sclerosis (SSc), facilitates earlier treatment. The objective of this study was to …

Novel treatment strategies in rheumatoid arthritis

GR Burmester, JE Pope - The Lancet, 2017 - thelancet.com
New treatment strategies have substantially changed the course of rheumatoid arthritis. Many
patients can achieve remission if the disease is recognised early and is treated promptly …

[HTML][HTML] Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

…, TP Anastassiades, JG Hanly, JE Pope… - … England Journal of …, 1997 - Mass Medical Soc
Background and Methods Osteoporosis is a recognized complication of corticosteroid
therapy. Whether it can be prevented is not known. We conducted a 12-month, randomized, …

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

…, R Stoilov, J Dunne, SR Johnson, JE Pope… - The Lancet …, 2020 - thelancet.com
Background A phase 2 trial of tocilizumab showed preliminary evidence of efficacy in systemic
sclerosis. We assessed skin fibrosis and systemic sclerosis-associated interstitial lung …

A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma

JE Pope, N Bellamy, JR Seibold… - … : Official Journal of …, 2001 - Wiley Online Library
Objective Early diffuse scleroderma (systemic sclerosis; SSc) has no proven treatment. This
study was undertaken to examine the efficacy of methotrexate (MTX) in improving the skin …

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

JE Pope, JJ Anderson, DT Felson - Archives of internal medicine, 1993 - jamanetwork.com
Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) have well-known gastrointestinal
and renal toxic reactions. Effects of NSAIDs on blood pressure are less appreciated. A …

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

…, RM Silver, RW Simms, J Varga, JE Pope - 2013 - deepblue.lib.umich.edu
Objective. The 1980 American College of Rheuma-tology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …